TIBER CREEK GROUP for MERCK & CO., INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues relating to Medicare Part D and Part B Pricing Reform, Issues related to Anti-Microbial Resistance (AMR).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| COREY MALMGREN | — |
| ANDREW MCKECHNIE | — |
Trade (domestic/foreign) TRD
Issues relating to Intellectual Property protections for COVID-19 treatments and vaccines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| COREY MALMGREN | — |
Taxation/Internal Revenue Code TAX
Issues related to corporate tax policy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| COREY MALMGREN | — |
Health Issues HCR
Issues related to antimicrobial resistance. H.R. 3932/S. 2076 - The PASTEUR Act of 2021. Consolidated Appropriations Act, 2023 (PL 117-328).
| Lobbyist | Covered position, as disclosed |
|---|---|
| COREY MALMGREN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.